CVS Valuation

CVS Health Corp

Add to Watchlist

Advanced Chart

60.700

+1.95(3.319%)1D

Overview
Forecast
Valuation
Earnings

CVS Relative Valuation

CVS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CVS is overvalued; if below, it's undervalued.

Historical Valuation

CVS Health Corp (CVS) is now in the Fair zone, suggesting that its current forward PE ratio of 9.60 is considered Fairly compared with the five-year average of 10.05. The fair price of CVS Health Corp (CVS) is between 56.00 to 69.61 according to relative valuation methord.

Relative Value

Fair Zone

56.00-69.61

Current Price：58.75

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.00

P/B

Median3y

1.25

Median5y

1.36

7.99

FCF Yield

Median3y

11.31

Median5y

12.00

Competitors Valuation Multiple

The average P/S ratio for CVS's competitors is 0.31, providing a benchmark for relative valuation. CVS Health Corp Corp (CVS) exhibits a P/S ratio of 0.19, which is -38.66% above the industry average. Given its robust revenue growth of 6.96%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap